Question 1

What is the catalog number for FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human) is 20691121.

Question 2

What sizes are available for FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

FMO10P CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD45 / LCA (135-4C5), CF647 conjugate, 0.1mg/mL

Anti-NSE/ENO2 Antibody Picoband®, FITC Conjugate

CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF405S conjugate, 0.1mg/mL

CD137L / 4-1BBL / TNFSF9 (CD137L/1547), 0.2mg/mL

Anti-TRMT1 Antibody Picoband®, Cy3 Conjugate

Anti-NM23A/NME1 Antibody Picoband® (PE Conjugate)